Borden 1987.
| Methods | RCT | |
| Participants | 361 randomized 275 evaluable | |
| Interventions | Dox q 3 weeks Dox weekly Dox + DTIC |
|
| Outcomes | Response Survival Toxicity PFI | |
| Notes | Two single‐agent doxorubicin arms included | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment (selection bias) | Low risk | A ‐ Adequate |